US$ 26.70
foxo4-dri senolytic 2023 2024 Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis Frontiers | Senolytic Peptide FOXO4-DRI
Description
MY BAC-T TEST FAILED FOR THE SECOND TIME

Join Waitlist Enter your email address to be notified when this item is back in stock
Clinical Context Epitalon should not be described as a cancer treatment or cancer cure

Yang XB, Bhatnagar RS, Li S, Oreffo RO